Showing 1 - 6 results of 6 for search 'Gwénaël Ferron', query time: 0.03s Refine Results
  1. 1
    Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer

    Metabolic activity determines survival depending on the level of lymph node involvement in cervical cancer by Alejandra Martinez, Elodie Chantalat, Martina Aida Angeles, Gwénaël Ferron, Anne Ducassou, Manon Daix, Justine Attal, Sarah Bétrian, Amélie Lusque, Erwan Gabiache

    Published 2022-07-01
    Get full text
    Article
  2. 2
    Assessing the implications of sentinel lymph node removal in cervical cancer: an immunogenetic perspective – a SENTICOL ancillary study

    Assessing the implications of sentinel lymph node removal in cervical cancer: an immunogenetic perspective – a SENTICOL ancillary study by Alejandra Martinez, Gwenael Ferron, Fabrice Lécuru, Patrice Mathevet, Maha Ayyoub, Anne-Sophie Navarro, Arash Rafii, Anna Salvioni, Marie Michelas, Gaurav Thareja, Françoise Lauzeral-Vizcaino, Najeeb Halabi, Eliane Mery-Lamarche, Noemie Thebault, Clara-Maria Scarlata, Jonathan Khalifa

    Published 2024-07-01
    Get full text
    Article
  3. 3
    Correction: Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer.

    Correction: Preferential Allele Expression Analysis Identifies Shared Germline and Somatic Driver Genes in Advanced Ovarian Cancer. by Najeeb M Halabi, Alejandra Martinez, Halema Al-Farsi, Eliane Mery, Laurence Puydenus, Pascal Pujol, Hanif G Khalak, Cameron McLurcan, Gwenael Ferron, Denis Querleu, Iman Al-Azwani, Eman Al-Dous, Yasmin A Mohamoud, Joel A Malek, Arash Rafii

    Published 2016-02-01
    Get full text
    Article
  4. 4
    PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression

    PPARγ activation modulates the balance of peritoneal macrophage populations to suppress ovarian tumor growth and tumor-induced immunosuppression by Hélène Authier, Agnès Coste, Gwenael Ferron, Mélissa Prat, Augustin Le Naour, Kimberley Coulson, Godefroy Jacquemin, Mouna Chirine Rahabi, Jean-Pierre Delord, Bettina Couderc, Clément Blot, Mathilde Romano, Marie-Laure Renoud, Mohamad AlaEddine, Khaddouj Benmoussa, Marie Salon, Mélissa Parny, Lise Lefèvre

    Published 2023-08-01
    Get full text
    Article
  5. 5
    Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression

    Circulating CD14high CD16low intermediate blood monocytes as a biomarker of ascites immune status and ovarian cancer progression by Hélène Authier, Agnès Coste, Alejandra Martinez, Gwenael Ferron, Laurence Gladieff, Mélissa Prat, Augustin Le Naour, Kimberley Coulson, Fanny Lemée, Hélène Leray, Godefroy Jacquemin, Mouna Chirine Rahabi, Léa Lemaitre, Jean-Marc Barret, Maha Ayyoub, Jean-Pierre Delord, Isabelle Tabah-Fisch, Jean-François Prost, Bettina Couderc

    Published 2020-05-01
    Get full text
    Article
  6. 6
    Overall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: a nationwide cohort analysis

    Overall survival in patients with re-excision of positive microscopic margins of limb and trunk wall soft tissue sarcoma operated outside of a reference center: a nationwide cohort... by Francois Gouin, Eberhard Stoeckle, Charles Honoré, Mickael Ropars, Mehrdad Jafari, Jean Camille Mattei, Alexandre Rochwerger, Sébastien Carrere, Denis Waast, Gwenaël Ferron, Jean-Christophe Machiavello, Philippe Anract, Frédéric Marchal, François Sirveaux, Oren Marco, Jérôme Guiramand, Brice Paquette, Antonio Di Marco, Sylvain Causeret, Jean-Marc Guilloit, Pauline Soibinet, Dimitri Tzanis, Pierre Gimbergues, Fabrice Fiorenza, Franck Dujardin, Louis R. Le Nail, Jean-Christophe Ruzic, Claire Chemin-Airiau, Magali Morelle, Pierre Meeus, Marie Karanian, François Le Loarer, Gualter Vaz, Jean-Yves Blay, on behalf of the NETSARC/RREPS and French Sarcoma Group-Groupe d’Etude des Tumeurs Osseuses (GSF-GETO) networks

    Published 2022-10-01
    Get full text
    Article

Search Tools: